https://markets.businessinsider.com/news/stocks/genenta-evolving-into-saentra-forge-continues-to-evaluate-strategic-options-for-its-original-biotechnology-platform-derived-from-the-research-of-professor-luigi-naldini-1035957040
Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original...
MILAN, March 24, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saentra Forge1, a strategic industrial consolida...
https://www.globenewswire.com/en/news-release/2024/10/02/2956792/0/en/Genenta-Secures-Approval-for-Innovative-Trial-for-Metastatic-Renal-Cell-Cancer.html
Genenta Secures Approval for Innovative Trial for
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer ...
securesapprovalinnovativetrial